Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Regavirumab (MCA C23), a human monoclonal antibody, targets cytomegalovirus (CMV), human serum albumin (HSA), and amino acetic acid [1].
説明 | Regavirumab (MCA C23), a human monoclonal antibody, targets cytomegalovirus (CMV), human serum albumin (HSA), and amino acetic acid [1]. |
分子量 | N/A |
CAS No. | 153101-26-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Regavirumab 153101-26-9 Inhibitor inhibitor inhibit